Magnitude of Multidrug Resistance Among Bacterial Isolates from Surgical Site Infections in Two National Referral Hospitals in Asmara, Eritrea
Overview
Authors
Affiliations
Background: The World Health Organization has emphasized the importance of understanding the epidemiology of MDR organisms from a local standpoint. Here, we report on a spectrum of bacteria associated with surgical site infections in two referral hospitals in Eritrea and the associated antibiotic susceptibility patterns.
Methods: This survey was conducted between February and June 2017. A total of 83 patients receiving treatment for various surgical conditions were included. Swabs from infected surgical sites were collected using Levine technique and processed using standard microbiological procedures. antimicrobial susceptibility testing was performed on Mueller-Hinton Agar by the Kirby-Bauer disk diffusion method following Clinical and Laboratory Standards Institute guidelines. The data were analyzed using SPSS version 20.
Results: A total of 116 isolates were recovered from 83 patients. In total, 67 (58%) and 49 (42%) of the isolates were Gram-positive and Gram-negative bacteria, respectively. The most common isolates included spp., spp., , spp spp., spp., and spp. In contrast, CONS, and were the predominant Gram-positive isolates. All the isolates were resistant to penicillin. MRSA phenotype was observed in 70% of the isolates. Vancomycin, clindamycin, and erythromycin resistance were observed in 60%, 25%, and 25% of the isolates, respectively. Furthermore, a high proportion (91%) of the Gram-negative bacteria were resistant to ampicillin and 100% of the and isolates were resistant to >5 of the tested antibiotics. The two isolates were resistant to >7 antimicrobial agents. We also noted that 4 (60%) of the isolates were resistant to >5 antimicrobial agents. Possible pan-drug-resistant (PDR) strains were also isolated.
Conclusion: Due to the high frequency of MDR isolates reported in this study, the development and implementation of suitable infection control policies and guidelines is imperative.
Andemichael Y, Habtetsion E, Gulbet H, Eman M, Achila O, Mengistu S Ann Clin Microbiol Antimicrob. 2025; 24(1):15.
PMID: 39984936 PMC: 11846260. DOI: 10.1186/s12941-025-00780-0.
Monk E, Jones T, Bongomin F, Kibone W, Nsubuga Y, Ssewante N PLOS Glob Public Health. 2024; 4(4):e0003077.
PMID: 38626068 PMC: 11020607. DOI: 10.1371/journal.pgph.0003077.
Hussein K, Tesfai B, Frezgi O, Hayelom H, Gebremeskel Y, Werede A Biomed Res Int. 2024; 2024:7193490.
PMID: 38577704 PMC: 10994703. DOI: 10.1155/2024/7193490.